Identification and development of the 1,4-benzodiazepin-2-one and quinazoline-2,4-dione scaffolds as submicromolar inhibitors of HAT
作者:Rachel L. Clark、Carol J. Clements、Michael P. Barrett、Simon P. Mackay、Rajendra P. Rathnam、George Owusu-Dapaah、John Spencer、Judith K. Huggan
DOI:10.1016/j.bmc.2012.08.049
日期:2012.10
A library of 1,4-benzodiazepines has been synthesised and evaluated for activity against Trypanosoma brucei, a causative parasite of Human African Trypanosomiasis (HAT). The most potent of these derivatives has an MIC value of 0.97 μM. Herein we report the design, synthesis and biological evaluation of the abovementioned compounds.
The chemistry of 2<i>H</i>-3,1-benzoxazine-2,4(1<i>H</i>)dione (isatoic anhydrides) 1. The synthesis of<i>N</i>-substituted 2<i>H</i>-3,1-benzoxazine-2,4(1<i>H</i>)diones
作者:Goetz E. Hardtmann、Gabor Koletar、Oskar R. Pfister
DOI:10.1002/jhet.5570120325
日期:1975.6
Three methods for the preparation of N-substituted 2H-3,1-benzoxazine-2,4(1H)diones (isatoicanhydrides) (1) utilizing 2-chloro-, 2-nitrobenzoic acids and N-unsubstituted isatoicanhydrides as starting materials, are described.
三种制备N-取代的2 H -3,1-苯并恶嗪-2,4(1 H)二酮(乙酸酐)的方法(1)使用2-氯-,2-硝基苯甲酸和N-未取代的等角酸酐作为制备方法描述了起始材料。
4-Alkyl-pyrazolo[5,1-b]-quinazolin-9(4H)-ones and anti-allergic
申请人:Warner-Lambert Company
公开号:US04261997A1
公开(公告)日:1981-04-14
Certain pyrazolo[5,1-b]quinazolin-9(4H)-ones are disclosed. These compounds prevent the allergic response in mammals.
Anthranilamide and 2-amino-heteroarene-carboxamide compounds
申请人:Conte Aurelia
公开号:US20070219261A1
公开(公告)日:2007-09-20
Compounds of formula I
processes for their preparation, their use as pharmaceuticals and to pharmaceutical compositions comprising them.
化学式为I的化合物,制备它们的方法,它们作为药物的用途以及包含它们的药物组合物。
Pyrazolo (5,1-b) quinazolin-9(4H)-one derivatives, process for their preparation and pharmaceutical compositions containing them
申请人:WARNER-LAMBERT COMPANY
公开号:EP0015065A1
公开(公告)日:1980-09-03
Compounds of formula:
wherein X is hydrogen, hydroxy, alkyl, alkoxy halogen, trifluoromethyl, or SOnR wherein R is alkyl and n is 0,1 or 2; Y is hydrogen, hydroxy, alkyl, alkoxy, or 2-tetrahydrothienyl; R1 is hydrogen or alkyl, Z is COOH,
Their preparation and pharmaceutical compositions comprising an anti-allergic effective amount of a compound of the formula I.
式中的化合物:
其中 X 是氢、羟基、烷基、烷氧基卤素、三氟甲基或 SOnR,其中 R 是烷基,n 是 0、1 或 2;Y 是氢、羟基、烷基、烷氧基或 2-四氢噻吩基;R1 是氢或烷基,Z 是 COOH、
含有抗过敏有效量的式 I 化合物的制剂和药物组合物。